{
    "nctId": "NCT03705429",
    "briefTitle": "A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer",
    "officialTitle": "A Multi-Centre Randomized Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 51,
    "primaryOutcomeMeasure": "Feasibility of performing a pragmatic clinical trial with an Integrated Consent Model.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with HER-2 positive early stage breast cancer for whom TC-H or weekly P-H is being considered.\n* Able to provide verbal consent.\n* Willing to complete study related-questionnaires\n\nExclusion Criteria:\n\n* Unable to give informed consent or complete questionnaires",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}